IBA white paper: treating pediatric tumors with proton therapy
Current practice, opportunities and challenges
The largest consensus on the preferability of proton over photon radiation therapy is in pediatric oncology. Counting 70-80% survival rates, finding solutions that positively impact quality of life outcomes has become a growing focal point among pediatric oncologists. This white paper presents clinical outcomes data that proton therapy provides an effective means to achieve this end.